FLI1 Expression is Correlated with Breast Cancer Cellular Growth, Migration, and Invasion and Altered Gene Expression

[1]  Paul E. Anderson,et al.  Predictive modeling of lung cancer recurrence using alternative splicing events versus differential expression data , 2014, 2014 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology.

[2]  Mark Stitt,et al.  RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics , 2012, Nucleic Acids Res..

[3]  T. Kaisho,et al.  The Ets Transcription Factor Spi-B Is Essential for the Differentiation of Intestinal Microfold (M) Cells , 2012, Nature Immunology.

[4]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[5]  Johan Staaf,et al.  GOBO: Gene Expression-Based Outcome for Breast Cancer Online , 2011, PloS one.

[6]  David P Turner,et al.  Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms. , 2011, Genes & cancer.

[7]  Massimo Cristofanilli,et al.  Molecular mechanisms of metastasis in breast cancer—clinical applications , 2010, Nature Reviews Clinical Oncology.

[8]  Y. Asano,et al.  The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis. , 2010, Journal of dermatological science.

[9]  A. Nekrutenko,et al.  Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences , 2010, Genome Biology.

[10]  S. Salzberg,et al.  Transcript assembly and abundance estimation from RNA-Seq reveals thousands of new transcripts and switching among isoforms , 2010, Nature biotechnology.

[11]  D. Watson,et al.  Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. , 2010, The American journal of pathology.

[12]  David P Turner,et al.  Transcriptional Regulation of p21/CIP1 Cell Cycle Inhibitor by PDEF Controls Cell Proliferation and Mammary Tumor Progression* , 2010, The Journal of Biological Chemistry.

[13]  D. Watson,et al.  Transcription Factor Fli1 Regulates Collagen Fibrillogenesis in Mouse Skin , 2008, Molecular and Cellular Biology.

[14]  Dennis B. Troup,et al.  NCBI GEO: archive for high-throughput functional genomic data , 2008, Nucleic Acids Res..

[15]  David P Turner,et al.  MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. , 2008, Cancer research.

[16]  V. Findlay,et al.  Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. , 2008, Molecular biology of the cell.

[17]  R. Hill,et al.  p53 binding to the p21 promoter is dependent on the nature of DNA damage , 2008, Cell cycle.

[18]  W. Jiang,et al.  NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress. , 2008, Current cancer drug targets.

[19]  J. Hamada,et al.  Functional roles of Fli‐1, a member of the Ets family of transcription factors, in human breast malignancy , 2007, Cancer science.

[20]  J. Rosen,et al.  Modelling breast cancer: one size does not fit all , 2007, Nature Reviews Cancer.

[21]  B. Rubino,et al.  The role of epithelial-mesenchymal transition in cancer pathology. , 2007, Pathology.

[22]  M. Bhasin,et al.  Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. , 2007, Cancer research.

[23]  David P Turner,et al.  Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. , 2007, Cancer research.

[24]  Jin He,et al.  Profile of Ets gene expression in human breast carcinoma , 2007, Cancer biology & therapy.

[25]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[26]  M. Markiewicz,et al.  Fli1 and Ets1 Have Distinct Roles in Connective Tissue Growth Factor/CCN2 Gene Regulation and Induction of the Profibrotic Gene Program* , 2006, Journal of Biological Chemistry.

[27]  M. Duffy,et al.  Ets2 transcription factor in normal and neoplastic human breast tissue. , 2006, European journal of cancer.

[28]  Shridar Ganesan,et al.  X chromosomal abnormalities in basal-like human breast cancer. , 2006, Cancer cell.

[29]  A. Seth,et al.  ETS transcription factors and their emerging roles in human cancer. , 2005, European journal of cancer.

[30]  D. Cervi,et al.  Direct transcriptional regulation of MDM2 by Fli-1 , 2005, Oncogene.

[31]  D. Watson,et al.  Ets-dependent Regulation of Target Gene Expression during Megakaryopoiesis* , 2004, Journal of Biological Chemistry.

[32]  F. Révillion,et al.  Prognostic Value of ERM Gene Expression in Human Primary Breast Cancers , 2004, Clinical Cancer Research.

[33]  M. Duffy,et al.  Overexpression of the Ets-1 transcription factor in human breast cancer , 2004, British Journal of Cancer.

[34]  Wei Wang,et al.  A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. , 2004, Cancer cell.

[35]  David Botstein,et al.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. , 2004, Molecular biology of the cell.

[36]  C. Hauser,et al.  Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors* , 2004, Journal of Biological Chemistry.

[37]  V. Sementchenko,et al.  Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. , 2003, Cancer research.

[38]  D. Watson,et al.  Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. , 2003, The American journal of pathology.

[39]  P. Jackers,et al.  Fli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[40]  Hiroshi Kawada,et al.  Defective Megakaryopoiesis and Abnormal Erythroid Development inFli-1 Gene-Targeted Mice , 2001, International journal of hematology.

[41]  W. Folk,et al.  Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers. , 2001, European journal of cancer.

[42]  Y. Ben-David,et al.  The role of Fli-1 in normal cell function and malignant transformation , 2000, Oncogene.

[43]  D. Watson,et al.  Hemorrhage, Impaired Hematopoiesis, and Lethality in Mouse Embryos Carrying a Targeted Disruption of the Fli1Transcription Factor , 2000, Molecular and Cellular Biology.

[44]  R Favier,et al.  Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. , 2000, Immunity.

[45]  A. Tamir,et al.  Fli-1, an Ets-Related Transcription Factor, Regulates Erythropoietin-Induced Erythroid Proliferation and Differentiation: Evidence for Direct Transcriptional Repression of the Rb Gene during Differentiation , 1999, Molecular and Cellular Biology.

[46]  K. Chew,et al.  HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer , 1997, Oncogene.

[47]  Wen-Lin Kuo,et al.  ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis , 1997, Oncogene.

[48]  N. Bhat,et al.  Generation and characterization of monoclonal antibodies against the ERGB/FLI-1 transcription factor. , 1995, Hybridoma.

[49]  R. Cardiff,et al.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.

[50]  A. Bernstein,et al.  Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[52]  K. Murphy,et al.  Role for SpiC in the development of red pulp macrophages and splenic iron homeostasis , 2008 .

[53]  Bongsoo Park,et al.  BMC Genomics , 2007 .